New clinical trial data for canagliflozin confirmed previously noted risk about fractures and reduced bone mineral density in the hip and spine, prompting the FDA to revise the product label. News Alerts …read more
Each fall, as part of their residency applications, medical students around the country struggle to describe the reasons they have picked their chosen specialty. We all have a sense of what attracts… …read more
Tandem’s system is the first insulin pump/continuous glucose monitor combination with a touch screen display of both glucose trend and insulin delivery information. FDA Approvals …read more
Dr Andrew Kaunitz summarizes the main points of his recent review article on treating menopausal symptoms. Medscape Ob/Gyn …read more
“I really did not feel like I fitted the box.” New research indicates the need for postnatal support that encompasses all mental health issues, not only postnatal depression. …read more
Women provide most of the informal unpaid care to family members with the disease and bear 6 times the cost compared to men, study out today saysWomen are not only at greater risk of developing… …read more
As an aid to clinical decision-making, a new review looks at the evidence on proposed treatments for premenstrual dysphoric disorder – a severe form of premenstrual syndrome. …read more
What is happening in week 10 of your pregnancy? Your baby is now the size of a prune and because of the formation of your baby’s vocal cords, he or she is able to make sounds. …read more